MedTrace Logo

Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography

NCT06484231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-08-12

No results posted yet for this study

Summary

This study aims to evaluate the necessity and effectiveness of using low molecular weight heparin (LMWH) for prophylaxis in the postoperative period in patients who underwent lobectomy due to malignancy, using thromboelastography.Blood samples taken from the patients before low molecular weight heparin prophylaxis (preoperative), before prophylaxis in the postoperative period (postoperative day 1) and after the start of postoperative prophylaxis (postoperative day 3) will be examined by thromboelastography.

Conditions

  • Malignancy

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Gizem Kececi Ozgur · Ege University Faculty of Medicine, Department of Thoracic Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2025-08-06
Completion
2025-08-06

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484231 on ClinicalTrials.gov